Luciana Molinero to Survival Analysis
This is a "connection" page, showing publications Luciana Molinero has written about Survival Analysis.
Connection Strength
0.067
-
First-line atezolizumab plus nab-paclitaxel for unresectable, locally advanced, or metastatic triple-negative breast cancer: IMpassion130 final overall survival analysis. Ann Oncol. 2021 08; 32(8):983-993.
Score: 0.037
-
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2018 11 29; 379(22):2108-2121.
Score: 0.031